These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20551262)

  • 1. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
    Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
    Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
    Yang HM; Cabral E; Dadras SS; Cassarino DS
    Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
    Jakobiec FA; Werdich X
    Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry in ocular carcinomas.
    Sramek B; Lisle A; Loy T
    J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor).
    Mulay K; White VA; Shah SJ; Honavar SG
    Can J Ophthalmol; 2014 Aug; 49(4):326-32. PubMed ID: 25103648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sebaceous carcinoma: an immunohistochemical reappraisal.
    Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
    Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological review of sebaceous carcinoma of the eyelid.
    Pereira PR; Odashiro AN; Rodrigues-Reyes AA; Correa ZM; de Souza Filho JP; Burnier MN
    J Cutan Pathol; 2005 Aug; 32(7):496-501. PubMed ID: 16008694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance?
    Mulay K; Shah SJ; Aggarwal E; White VA; Honavar SG
    Acta Ophthalmol; 2014 Dec; 92(8):e681-7. PubMed ID: 24930483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on the expression of p16 protein and bcl-2 protein in cutaneous eyelid tumors].
    Niu Y; Liu F; Meng X; Wang H; Lin H
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):259-62, 15. PubMed ID: 11853608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
    Ansai S; Arase S; Kawana S; Kimura T
    J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
    Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
    Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
    Niu Y; Wang H; Ji J; Lin H; Zhang A
    Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
    Yu L; Galan A; McNiff JM
    J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology in the diagnosis and treatment of palpebral tumors].
    Pluot M; Ducasse A
    J Fr Ophtalmol; 2003 Jan; 26(1):77-83. PubMed ID: 12610415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical distinction of ocular sebaceous carcinoma from basal cell and squamous cell carcinoma.
    Sinard JH
    Arch Ophthalmol; 1999 Jun; 117(6):776-83. PubMed ID: 10369589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours.
    Reszeć J; Kańczuga-Koda L; Sulkowska M; Koda M; Cylwik J; Barwijuk-Machała M; Sulkowski S
    Folia Morphol (Warsz); 2004 Feb; 63(1):95-8. PubMed ID: 15039910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
    Heyl J; Mehregan D
    J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.
    Arits AH; Van Marion AM; Lohman BG; Thissen MR; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Eur J Dermatol; 2011; 21(6):870-3. PubMed ID: 21865121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Palpebral tumors: clinical and diagnostic considerations].
    Lasudry J
    J Fr Ophtalmol; 2003 Jan; 26(1):70-6. PubMed ID: 12610414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.